Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
How has CSL (United Kingdom)'s publication output changed over time?
ScholarIQpublication output · 1991–2026
Output grew0% over the shown period — from 1 works in 1991 to 1 in 2026.
1
1
1
1
1
1
1
1
1
1
1991199820012012201520192021202220232026
Who are the most-cited researchers behind CSL (United Kingdom)?
ScholarIQtop researchers by citations
What are the most-cited papers on CSL (United Kingdom)?
ScholarIQmost cited works
Cost-effectiveness of tapentadol prolonged release compared with oxycodone controlled release in the UK in patients with severe non-malignant chronic pain who failed 1st line treatment with morphine
R. Ikenberg, N. Hertel, Andrew Moore, M Obradović, Garth Baxter, Pete Conway, Hiltrud Liedgens
Journal of Medical Economics. 201228 CitationsOPEN ACCESS
Evaluation of the Cost-Effectiveness of Iron Formulations for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease in the UK
A Aksan, Ian Beales, Garth Baxter, Antonio Ramírez de Arellano, Simona Gavata, William J. Valentine, Barnaby Hunt
ClinicoEconomics and Outcomes Research. 202124 CitationsOPEN ACCESS
Benefit of Helicobacter pylori eradication in the treatment of ulcer-like dyspepsia in primary care
Richard D. Stevens, Garth Baxter
Gastroenterology. 200116 Citations
A cost-effectiveness analysis of patiromer in the UK: evaluation of hyperkalaemia treatment and lifelong RAASi maintenance in chronic kidney disease patients with and without heart failure
Thomas Ward, Ruth D. Lewis, Tray Brown, Garth Baxter, Antonio Ramírez de Arellano
BMC Nephrology. 20237 CitationsOPEN ACCESS
How much of the research on CSL (United Kingdom) is open access?
ScholarIQopen access share
64%OPEN ACCESS
Gold
27%
Green
9%
Hybrid
9%
Bronze
18%
Closed
36%